Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Lexeo Therapeutics, Inc.(LXEO) | 0 | 2,157,623 | +2,157,623 | $0 | $28.96M | 23.46% | +$28.96M |
| Replimune Group, Inc.(REPL) | 3,001,319 | 3,001,319 | 0 | $51.35M | $25.30M | 20.50% | -$26.05M |
| Nuvation Bio Inc.CL A(NUVB) | 15,072,340 | 15,072,340 | 0 | $20.20M | $22.76M | 18.44% | +$2.56M |
| enGene Holdings Inc. COM | 0 | 1,131,175 | +1,131,175 | $0 | $10.44M | 8.46% | +$10.44M |
| Morphic Holding | 309,846 | 309,846 | 0 | $7.10M | $8.95M | 7.25% | +$1.85M |
| Spruce Biosciences | 2,161,022 | 2,161,022 | 0 | $4.88M | $6.33M | 5.13% | +$1.45M |
| Kronos Bio | 3,818,283 | 3,818,283 | 0 | $4.96M | $4.77M | 3.87% | -$190.9K |
| Ikena Oncology | 2,249,123 | 2,249,123 | 0 | $9.74M | $4.43M | 3.59% | -$5.31M |
| Sana Biotechnology, Inc.(SANA) | 843,750 | 843,750 | 0 | $3.27M | $3.44M | 2.79% | +$177.2K |
| Theseus Pharmaceuticals | 711,479 | 711,479 | 0 | $1.91M | $2.88M | 2.33% | +$967.6K |
| Immunic, Inc.(IMUX) | 1,788,160 | 1,788,160 | 0 | $2.63M | $2.68M | 2.17% | +$53.6K |
| Syros Pharmaceuticals | 251,270 | 251,270 | 0 | $992.5K | $1.96M | 1.59% | +$964.9K |
| enGene Holdings Inc.WARRANT *W EXP 10/31/202 | 0 | 475,077 | +475,077 | $0 | $403.8K | 0.33% | +$403.8K |
| Senti Biosciences, Inc. | 195,792 | 195,792 | 0 | $80.9K | $129.2K | 0.10% | +$48.4K |
| Alpine Immune SciencesCommon Stock | 153,700 | 0 | -153,700 | $1.76M | $0 | — | -$1.76M |